AAAAAA

   
Results: 1-24 |
Results: 24
SYNTHESIS, IN-VITRO BINDING, AND TISSUE DISTRIBUTION OF RADIOIODINATED 2-[I-125]N-(N-BENZYLPIPERIDIN-4-YL)-2-IODO BENZAMIDE, 2-[I-125]BP - A POTENTIAL SIGMA-RECEPTOR MARKER FOR HUMAN PROSTATE TUMORS
Authors: JOHN CS GULDEN ME LI JH BOWEN WD MCAFEE JG THAKUR ML
Citation: Cs. John et al., SYNTHESIS, IN-VITRO BINDING, AND TISSUE DISTRIBUTION OF RADIOIODINATED 2-[I-125]N-(N-BENZYLPIPERIDIN-4-YL)-2-IODO BENZAMIDE, 2-[I-125]BP - A POTENTIAL SIGMA-RECEPTOR MARKER FOR HUMAN PROSTATE TUMORS, Nuclear medicine and biology, 25(3), 1998, pp. 189-194
COMPARATIVE BIODISTRIBUTIONS OF A RADIOIODINATED BENZAMIDE IN NUDE-MICE AND C57 BLACK MICE BEARING B16 MELANOMA XENOGRAFTS
Authors: JOHN CS GEYER BC VILNER BJ LIM BB BOWEN WD
Citation: Cs. John et al., COMPARATIVE BIODISTRIBUTIONS OF A RADIOIODINATED BENZAMIDE IN NUDE-MICE AND C57 BLACK MICE BEARING B16 MELANOMA XENOGRAFTS, The Journal of nuclear medicine, 39(5), 1998, pp. 1003-1003
RADIOIODINATED (2-PIPERIDINYL-AMINOETHYL)-4-IODOBENZAMIDE (IPAB), A SIGMA-1 RECEPTOR-LIGAND, FOR DELETING TUMOR PROLIFERATION - IN-VITRO VALIDATION
Authors: ZAMORA PO JOHN CS
Citation: Po. Zamora et Cs. John, RADIOIODINATED (2-PIPERIDINYL-AMINOETHYL)-4-IODOBENZAMIDE (IPAB), A SIGMA-1 RECEPTOR-LIGAND, FOR DELETING TUMOR PROLIFERATION - IN-VITRO VALIDATION, The Journal of nuclear medicine, 39(5), 1998, pp. 1006-1006
INCREASED BINDING TO SIGMA-SITES OF N-[1'(2-PIPERIDINYL)ETHYL]-4-[I-125]-IODOBENZAMIDE (I-125-PAB) WITH ONSET OF TUMOR-CELL PROLIFERATION
Authors: ZAMORA PO MOODY TW JOHN CS
Citation: Po. Zamora et al., INCREASED BINDING TO SIGMA-SITES OF N-[1'(2-PIPERIDINYL)ETHYL]-4-[I-125]-IODOBENZAMIDE (I-125-PAB) WITH ONSET OF TUMOR-CELL PROLIFERATION, Life sciences (1973), 63(18), 1998, pp. 1611-1618
SUBSTITUTED HALOGENATED ARYLSULFONAMIDES - A NEW CLASS OF SIGMA-RECEPTOR BINDING TUMOR IMAGING AGENTS
Authors: JOHN CS LIM BB VILNER BJ GEYER BC BOWEN WD
Citation: Cs. John et al., SUBSTITUTED HALOGENATED ARYLSULFONAMIDES - A NEW CLASS OF SIGMA-RECEPTOR BINDING TUMOR IMAGING AGENTS, Journal of medicinal chemistry, 41(14), 1998, pp. 2445-2450
TC-99M-LABELED SIGMA-RECEPTOR-BINDING COMPLEX - SYNTHESIS, CHARACTERIZATION, AND SPECIFIC BINDING TO HUMAN DUCTAL BREAST-CARCINOMA (T47D) CELLS
Authors: JOHN CS LIM BB GEYER BC VILNER BJ BOWEN WD
Citation: Cs. John et al., TC-99M-LABELED SIGMA-RECEPTOR-BINDING COMPLEX - SYNTHESIS, CHARACTERIZATION, AND SPECIFIC BINDING TO HUMAN DUCTAL BREAST-CARCINOMA (T47D) CELLS, Bioconjugate chemistry, 8(3), 1997, pp. 304-309
SYNTHESIS AND EVALUATION OF [F-18] LABELED BENZAMIDES - HIGH-AFFINITYSIGMA-RECEPTOR LIGANDS FOR PET IMAGING
Authors: DENCE CS JOHN CS BOWEN WD WELCH MJ
Citation: Cs. Dence et al., SYNTHESIS AND EVALUATION OF [F-18] LABELED BENZAMIDES - HIGH-AFFINITYSIGMA-RECEPTOR LIGANDS FOR PET IMAGING, Nuclear medicine and biology, 24(4), 1997, pp. 333-340
TC-99M LABELED ETHYLENEDIAMINES - QUEST FROM SIGMA-RECEPTOR CHELATES
Authors: JOHN CS VENUGOPAL R GEYER BC LIM BB
Citation: Cs. John et al., TC-99M LABELED ETHYLENEDIAMINES - QUEST FROM SIGMA-RECEPTOR CHELATES, The Journal of nuclear medicine, 38(5), 1997, pp. 798-798
SYNTHESIS, IN-VITRO VALIDATION AND IN-VIVO PHARMACOKINETICS OF [I-125] PHENYL)ETHYL]-N-METHYL-2-(1-PIPERIDINYL)ETHYLAMINE - A HIGH-AFFINITYLIGAND FOR IMAGING SIGMA-RECEPTOR POSITIVE TUMORS
Authors: JOHN CS GULDEN ME VILNER BJ BOWEN WD
Citation: Cs. John et al., SYNTHESIS, IN-VITRO VALIDATION AND IN-VIVO PHARMACOKINETICS OF [I-125] PHENYL)ETHYL]-N-METHYL-2-(1-PIPERIDINYL)ETHYLAMINE - A HIGH-AFFINITYLIGAND FOR IMAGING SIGMA-RECEPTOR POSITIVE TUMORS, Nuclear medicine and biology, 23(6), 1996, pp. 761-766
SYNTHESIS, IN-VITRO AND IN-VIVO STUDIES OF RADIOIODINATED ARYLETHYLENEDIAMINES (AEDS) - NEW SIGMA-RECEPTOR PROBES
Authors: JOHN CS LIM BB VILNER BJ GEYER BC BOWEN WD
Citation: Cs. John et al., SYNTHESIS, IN-VITRO AND IN-VIVO STUDIES OF RADIOIODINATED ARYLETHYLENEDIAMINES (AEDS) - NEW SIGMA-RECEPTOR PROBES, The Journal of nuclear medicine, 37(5), 1996, pp. 16-16
CHARACTERIZATION AND TARGETING OF SIGMA-RECEPTOR BINDING-SITES IN HUMAN PROSTATE TUMOR-CELLS
Authors: JOHN CS VENUGOPAL R LI J BOWEN WD VARMA VM THAKUR ML
Citation: Cs. John et al., CHARACTERIZATION AND TARGETING OF SIGMA-RECEPTOR BINDING-SITES IN HUMAN PROSTATE TUMOR-CELLS, The Journal of nuclear medicine, 37(5), 1996, pp. 933-933
CHARACTERIZATION OF SIGMA-RECEPTOR BINDING-SITES IN HUMAN BIOPSIED SOLID BREAST-TUMORS
Authors: JOHN CS VILNER BJ SCHWARTZ AM BOWEN WD
Citation: Cs. John et al., CHARACTERIZATION OF SIGMA-RECEPTOR BINDING-SITES IN HUMAN BIOPSIED SOLID BREAST-TUMORS, The Journal of nuclear medicine, 37(5), 1996, pp. 1194-1194
PREPARATION AND PRELIMINARY EVALUATION OF 4-[AT-211]ASTATO-N-PIPERIDINOETHYL BENZAMIDE
Authors: GARG PK JOHN CS ZALUTSKY MR
Citation: Pk. Garg et al., PREPARATION AND PRELIMINARY EVALUATION OF 4-[AT-211]ASTATO-N-PIPERIDINOETHYL BENZAMIDE, Nuclear medicine and biology, 22(4), 1995, pp. 467-473
N,N'-ETHYLENE-DI-L-CYSTEINE (EC) COMPLEXES OF GA(III) AND IN(III) - MOLECULAR MODELING, THERMODYNAMIC STABILITY AND IN-VIVO STUDIES
Authors: ANDERSON CJ JOHN CS LI YJJ HANCOCK RD MCCARTHY TJ MARTELL AE WELCH MJ
Citation: Cj. Anderson et al., N,N'-ETHYLENE-DI-L-CYSTEINE (EC) COMPLEXES OF GA(III) AND IN(III) - MOLECULAR MODELING, THERMODYNAMIC STABILITY AND IN-VIVO STUDIES, Nuclear medicine and biology, 22(2), 1995, pp. 165-173
SIGMA-RECEPTORS ARE EXPRESSED IN HUMAN NONSMALL CELL LUNG-CARCINOMA
Authors: JOHN CS BOWEN WD VARMA VM MCAFEE JG MOODY TW
Citation: Cs. John et al., SIGMA-RECEPTORS ARE EXPRESSED IN HUMAN NONSMALL CELL LUNG-CARCINOMA, Life sciences, 56(26), 1995, pp. 2385-2392
SIGMA-1 AND SIGMA-2 RECEPTORS ARE EXPRESSED IN A WIDE VARIETY OF HUMAN AND RODENT TUMOR-CELL LINES
Authors: VILNER BJ JOHN CS BOWEN WD
Citation: Bj. Vilner et al., SIGMA-1 AND SIGMA-2 RECEPTORS ARE EXPRESSED IN A WIDE VARIETY OF HUMAN AND RODENT TUMOR-CELL LINES, Cancer research, 55(2), 1995, pp. 408-413
SYNTHESIS AND PHARMACOLOGICAL CHARACTERIZATION OF [I-125]-N-(N-BENZYLPIPERIDIN-4-YL)-4-IODOBENZAMIDE - A HIGH-AFFINITY SIGMA-RECEPTOR LIGAND FOR POTENTIAL IMAGING OF BREAST-CANCER
Authors: JOHN CS VILNER BJ GULDEN ME EFANGE SMN LANGASON RB MOODY TW BOWEN WD
Citation: Cs. John et al., SYNTHESIS AND PHARMACOLOGICAL CHARACTERIZATION OF [I-125]-N-(N-BENZYLPIPERIDIN-4-YL)-4-IODOBENZAMIDE - A HIGH-AFFINITY SIGMA-RECEPTOR LIGAND FOR POTENTIAL IMAGING OF BREAST-CANCER, Cancer research, 55(14), 1995, pp. 3022-3027
SYNTHESIS AND CHARACTERIZATION OF (N-BENZYLPIPERIDIN-4-YL)-4-IODOBENZAMIDE, 4-IBP - A NEW SIGMA-LIGAND - HIGH-AFFINITY BINDING TO MCF-7 BREAST-CANCER CELLS
Authors: JOHN CS BOWEN WD VILNER BJ MCAFEE JG
Citation: Cs. John et al., SYNTHESIS AND CHARACTERIZATION OF (N-BENZYLPIPERIDIN-4-YL)-4-IODOBENZAMIDE, 4-IBP - A NEW SIGMA-LIGAND - HIGH-AFFINITY BINDING TO MCF-7 BREAST-CANCER CELLS, The Journal of nuclear medicine, 35(5), 1994, pp. 160000246-160000246
SIGMA-RECEPTORS ARE EXPRESSED IN NONSMALL CELL LUNG-CARCINOMA - POTENTIAL USE FOR TUMOR VISUALIZATION
Authors: JOHN CS MOODY TW BOWEN WD VILNER BJ VARMA VM MCAFEE JG
Citation: Cs. John et al., SIGMA-RECEPTORS ARE EXPRESSED IN NONSMALL CELL LUNG-CARCINOMA - POTENTIAL USE FOR TUMOR VISUALIZATION, The Journal of nuclear medicine, 35(5), 1994, pp. 160000248-160000248
SYNTHESIS AND CHARACTERIZATION OF [I-125] N-(N-BENZYLPIPERIDIN-4-YL)-4-IODOBENZAMIDE, A NEW SIGMA-RECEPTOR RADIOPHARMACEUTICAL - HIGH-AFFINITY BINDING TO MCF-7 BREAST-TUMOR CELLS
Authors: JOHN CS VILNER BJ BOWEN WD
Citation: Cs. John et al., SYNTHESIS AND CHARACTERIZATION OF [I-125] N-(N-BENZYLPIPERIDIN-4-YL)-4-IODOBENZAMIDE, A NEW SIGMA-RECEPTOR RADIOPHARMACEUTICAL - HIGH-AFFINITY BINDING TO MCF-7 BREAST-TUMOR CELLS, Journal of medicinal chemistry, 37(12), 1994, pp. 1737-1739
PALLADIUM(II) COMPLEXES OF N2O2 AND N2S2 LIGANDS - SYNTHESES AND X-RAY CRYSTAL-STRUCTURES
Authors: PILLAI MRA BARNES CL JOHN CS TROUTNER DE SCHLEMPER EO
Citation: Mra. Pillai et al., PALLADIUM(II) COMPLEXES OF N2O2 AND N2S2 LIGANDS - SYNTHESES AND X-RAY CRYSTAL-STRUCTURES, Journal of crystallographic and spectroscopic research, 23(12), 1993, pp. 949-953
AN ALTERNATE SYNTHESIS OF THIOLACTONE FOR LABELING BIOPEPTIDES WITH TC-99M
Authors: JOHN CS MCAFEE JG
Citation: Cs. John et Jg. Mcafee, AN ALTERNATE SYNTHESIS OF THIOLACTONE FOR LABELING BIOPEPTIDES WITH TC-99M, The Journal of nuclear medicine, 34(5), 1993, pp. 248-248
A MALIGNANT-MELANOMA IMAGING AGENT - SYNTHESIS, CHARACTERIZATION, IN-VITRO BINDING AND BIODISTRIBUTION OF ODINE-125-(2-PIPERIDINYLAMINOETHYL)4-IODOBENZAMIDE
Authors: JOHN CS BOWEN WD SAGA T KINUYA S VILNER BJ BAUMGOLD J PAIK CH REBA RC NEUMANN RD VARMA VM MCAFEE JG
Citation: Cs. John et al., A MALIGNANT-MELANOMA IMAGING AGENT - SYNTHESIS, CHARACTERIZATION, IN-VITRO BINDING AND BIODISTRIBUTION OF ODINE-125-(2-PIPERIDINYLAMINOETHYL)4-IODOBENZAMIDE, The Journal of nuclear medicine, 34(12), 1993, pp. 2169-2175
SYNTHESIS, CHARACTERIZATION AND BIODISTRIBUTION OF A NEW HEXADENTATE AMINETHIOL LIGAND LABELED WITH TC-99M
Authors: JOHN CS SCHLEMPER EO HOSAIN P PAIK CH REBA RC
Citation: Cs. John et al., SYNTHESIS, CHARACTERIZATION AND BIODISTRIBUTION OF A NEW HEXADENTATE AMINETHIOL LIGAND LABELED WITH TC-99M, International journal of radiation applicatons and instrumentation. Part B: Nuclear medicine and biology, 19(3), 1992, pp. 269-274
Risultati: 1-24 |